ArticleCureus2025
A Case of Metastatic Lung Adenocarcinoma, With Metastasis to the Brain, Spleen, Liver, and Bone, Mimicking Sarcoidosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung adenocarcinoma can radiologically and clinically mimic granulomatous disease, leading to diagnostic delays. Bilateral hilar and mediastinal lymphadenopathy, perilymphatic nodules, and partial corticosteroid responsiveness may anchor clinicians to a diagnosis of sarcoidosis. This case highlights the importance of maintaining a broad differential and pursuing a timely, tissue-based diagnosis when features evolve atypically. We report a previously healthy 49-year-old male, lifelong non-smoker, who presented with three months of progressive multisystem symptoms, including exertional dyspnea, nocturnal cough, constitutional complaints, neuropathic pain, visual auras, and intermittent paresthesia. Imaging revealed diffuse thoracic lymphadenopathy, pulmonary fibrosis, splenic and adrenal nodules, and multifocal enhancing brain lesions, while positron emission tomography (PET)-computed tomography (CT) demonstrated widespread fluorodeoxyglucose (FDG)-avid disease. Although sarcoidosis and infective granulomatous conditions were initially considered, a cervical lymph-node biopsy confirmed metastatic lung adenocarcinoma (stage IV). This case illustrates how radiologic mimicry and anchoring bias can delay the recognition of malignancy, emphasizes the non-specific nature of FDG avidity, and underscores the decisive role of histological confirmation. Early consideration of malignancy in "sarcoid-like" presentations, especially when systemic features or incomplete steroid response arise, is essential to ensure timely oncologic therapy and integration of supportive care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.